NuCana PLC (NCNA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.88M
Last updated: Nov 17, 2026 at 11:05 AM ET
NuCana PLC (NCNA) Financials: Revenue, Profit and Cash Flow
NuCana reported revenue of GBP 0 for the fiscal year ended Dec 31, 2025. That year, net income was GBP -29.35M, operating cash flow was GBP -7.47M and free cash flow was GBP -7.66M. The quarter ended Sep 30, 2026 had net income of GBP -1.59M.
Revenue and Margins
The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of GBP 20.11M.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | 0 | N/A | N/A | N/A | N/A |
| Dec 2024 | 0 | N/A | N/A | N/A | N/A |
| Dec 2023 | 0 | N/A | N/A | N/A | N/A |
| Dec 2022 | 0 | N/A | N/A | N/A | N/A |
| Dec 2021 | 0 | N/A | N/A | N/A | N/A |
| Dec 2020 | 0 | N/A | N/A | N/A | N/A |
| Dec 2019 | 0 | N/A | N/A | N/A | N/A |
| Dec 2018 | 0 | -100.0% | N/A | N/A | N/A |
| Dec 2017 | 283.00K | N/A | 100.0% | -7860.8% | -8157.2% |
| Dec 2016 | 0 | N/A | N/A | N/A | N/A |
Income Statement
In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 283.00K | 0 |
| Cost of revenue | 267.99K | N/A | N/A | N/A | N/A | N/A | 0 | 0 | 0 | 0 |
| Gross profit | -267.99K | N/A | N/A | N/A | N/A | N/A | 0 | 0 | 283.00K | 0 |
| Research and development | 12.74M | 18.02M | 25.06M | 36.43M | 36.83M | 25.90M | 19.73M | 16.85M | 17.67M | 7.90M |
| Operating income | -20.11M | -22.81M | -32.78M | -39.12M | -47.91M | -36.42M | -26.70M | -22.03M | -22.25M | -8.45M |
| Net income | -29.35M | -19.00M | -27.63M | -32.02M | -40.53M | -30.68M | -21.41M | -13.84M | -23.09M | -6.05M |
| EBITDA | N/A | -22.48M | -30.55M | N/A | -44.42M | -28.59M | 718.00K | 371.00K | 194.00K | 101.00K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit | -69.45K | -71.37K | -69.48K | -68.10K | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating income | -1.69M | -3.45M | -4.42M | -2.81M | -779.00K | -11.83M | -2.85M | -865.00K | -5.32M | -8.35M | -8.27M | -9.11M |
| Net income | -1.59M | -3.10M | -3.87M | -2.45M | -281.00K | -24.11M | -2.47M | -653.00K | -4.51M | -7.00M | -6.84M | -7.66M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of GBP 20.00K by 24.23M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 29.83M | 14.77M | 27.81M | 58.25M | 77.47M | 107.79M | 70.27M | 87.19M | 96.36M | 27.21M |
| Current assets | 26.86M | 12.27M | 25.02M | 54.92M | 71.61M | 101.81M | 65.15M | 83.59M | 93.98M | 25.82M |
| Cash and equivalents | 24.25M | 6.75M | 17.23M | 41.91M | 60.26M | 87.36M | 51.96M | 76.97M | 86.70M | 19.99M |
| Total liabilities | 5.51M | 8.82M | 12.92M | 19.75M | 11.93M | 8.56M | 6.75M | 5.59M | 2.94M | 1.97M |
| Short-term debt | 20.00K | 73.00K | 206.00K | 243.00K | 207.00K | 278.00K | 268.00K | 0 | 0 | 0 |
| Shareholder equity | 24.33M | 5.95M | 14.89M | 38.50M | 65.55M | 99.23M | 63.52M | 81.59M | 93.42M | 25.24M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 24.58M | 25.63M | 27.55M | 29.78M | 32.31M | 16.22M | 11.60M | 14.77M | 19.53M | 20.07M | 24.80M | 27.81M |
| Total liabilities | 4.89M | 5.49M | 5.19M | 5.50M | 6.39M | 8.83M | 7.43M | 8.82M | 15.19M | 16.27M | 14.67M | 12.92M |
| Cash and equivalents | 18.47M | 19.39M | 21.53M | 24.21M | 25.25M | 8.44M | 3.95M | 6.75M | 11.35M | 11.64M | 12.87M | 17.23M |
| Shareholder equity | 19.69M | 20.14M | 22.37M | 24.28M | 25.93M | 7.38M | 4.17M | 5.95M | 4.35M | 3.80M | 10.13M | 14.89M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -7.47M | -19.12M | -26.44M | -23.16M | -23.82M | -21.62M | -23.83M | -12.22M | -8.71M | -9.26M |
| Capital expenditures | 193.00K | 293.00K | 478.00K | 518.00K | 1.06M | 1.63M | 1.26M | 1.62M | 1.09M | 554.00K |
| Free cash flow | -7.66M | -19.41M | -26.92M | -23.68M | -24.89M | -23.25M | -25.09M | -13.85M | -9.80M | -9.82M |
| Investing cash flow | 159.00K | 79.00K | 2.89M | 120.00K | -3.56M | -1.31M | -145.00K | -651.00K | -933.00K | 14.93M |
| Financing cash flow | 25.01M | 8.18M | -53.00K | -161.00K | -98.00K | 61.80M | -47.00K | 207.00K | 77.75M | 200.00K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -1.50M | -1.93M | -3.18M | -930.00K | 1.28M | -4.49M | -3.11M | -7.46M | -4.60M | -1.18M | -5.88M | -77.00K |
| Capital expenditures | 0 | 34.00K | 77.00K | 50.00K | 47.00K | 57.00K | 39.00K | 51.00K | 63.00K | 98.00K | 81.00K | 97.00K |
| Free cash flow | -1.50M | -1.96M | -3.26M | -980.00K | 1.23M | -4.54M | -3.15M | -7.51M | -4.67M | -1.27M | -5.96M | -174.00K |
Frequently Asked Questions About NCNA
What is NuCana's annual revenue?
NuCana reported revenue of GBP 0 for the fiscal year ended Dec 31, 2025.
Is NuCana profitable?
No. NuCana reported net income of GBP -29.35M for the fiscal year ended Dec 31, 2025.
How much free cash flow does NCNA generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of GBP -7.47M minus capital expenditures of GBP 193.00K produced free cash flow of GBP -7.66M.
How much debt does NuCana have?
The balance sheet dated Dec 31, 2025 reported short-term debt of GBP 20.00K and cash and equivalents of GBP 24.25M.
NCNA pages: Overview, Financials, Competitors